IBM Watson, Celgene partner on cloud-based patient safety monitoring tool

Celgene and IBM are teaming up on a new patient safety monitoring platform to improve pharmacovigilance methods throughout the drug development process. The platform, dubbed IBM Watson for Patient Safety, will combine Watson's cognitive computing chops with Celgene's extensive experience in drug safety and risk management. It will be an outcome- and evidence-based drug safety decision support system for life sciences companies, the duo said in a statement. It will run on the Watson Health Cloud. The highly automated, modular, end-to-end drug safety platform will allow for the rapid collection, collation and automated analysis of vast amounts of data from a variety of sources, the companies said in a statement.